Patient Access to Newly Registered Anticancer Agents Webinar
Many new cancer medicines have been developed that can improve patients’ outcomes. However, access to these agents usually takes longer in Europe than in the United States (US), and varies greatly across EU countries.
Therefore, the Cancer Drug Development Forum will hold a live webinar, Patient Access to Newly Registered Anticancer Agents on Wednesday 9 December 2020 from 18:30 to 19:30 (CET) / 12:30 to 13:30 (EST) / 9:30 to 10:30 (PST). This live webinar comprises a 25-minute lecture given by Prof. Carin Uyl-de Groot (Erasmus University Rotterdam) followed by Prof. Francesco de Lorenzo (CDDF)’s 5-minute position statement and a 25-minute discussion session.
You will have the chance to learn more about the actual access to several recently registered cancer drugs in European countries following EMA marketing authorisation, and the implications for patients. The discussion will also give you the opportunity to learn about best practices related to general use of new drugs within Europe.